Covaxin: Will Covaxin beneficiaries have to wait longer for international travel?

New Delhi: During the Corona transition, many countries around the world began to formulate their own ‘travel policies’. Work is underway in many countries to formulate a ‘travel policy’ to allow citizens of other countries who have been vaccinated against Kovid to enter their country. However, it seems that Indian travelers taking both doses of the covacin vaccine manufactured by Bharat Biotech will not be able to travel abroad.

Countries are giving preference to vaccines permitted in their home country or vaccines permitted for emergency use by the World Health Organization (WHO) (EUL: Emergency Use Listing) to allow foreign visitors to enter their country.

The WHO’s list includes vaccines including Modern, P. Pfizer, AstraZeneca (two), Janssen (US and Netherlands) as well as Synopharm / BBIP, along with Serum Institute of India’s Covishield. However, the list does not include Bharat Biotech-developed covacin vaccine.

Although India Biotech is pursuing the inclusion of the vaccine in the WHO list, the document states that “more information is needed”.

Coronavirus: 2.57 lakh coronavirus and 4194 deaths in one day
covid vaccine: Serum officials say, ‘The idea of ​​shortage of vaccine came to the central government, yet …’

According to the World Health Organization, a meeting may be held in May-June. The decision is likely to be reconsidered by the WHO after the company submits the required documents. Each process is expected to take at least a week, experts say.

If a vaccine is not approved by other countries or is not included in the World Health Organization’s list, travelers who take advantage of the vaccine will be considered ‘non-vaccinated’.

Of course, beneficiaries of the ‘covacin’ vaccine are likely to be deprived of international travel permits for a few more months until this process is completed.

Supreme Court: ‘High courts should not issue orders from Corona which are impossible to enforce’
drdo: DRDO develops antibody detection test kit to help treat coronavirus